IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell Function

Area of Science:

• Immunology
• Molecular Biology
• Allergy Research

Background:

• Interleukin-33 (IL-33) is a key inflammatory cytokine implicated in allergic diseases like asthma.
• IL-33 signaling involves the ST2 receptor and shares pathways with Toll-like receptors (TLRs).
• The homeostatic control of IL-33 signaling remains incompletely understood.

Purpose of the Study:

• To investigate the potential role of microRNA-146a (miR-146a) as a feedback regulator of IL-33 signaling.
• To elucidate the function of miR-146a in IL-33-mediated mast cell activation.

Main Methods:

• Assessed miR-146a expression in mouse bone marrow-derived mast cells (BMMCs) and exosomes following IL-33 stimulation.
• Utilized miR-146a antagonists and miR-146a knockout BMMCs to evaluate IL-33-induced cytokine production.
• Examined in vivo miR-146a levels in plasma exosomes and IL-6 levels after IL-33 challenge in wild-type and mast cell-deficient mice.

Main Results:

• IL-33 stimulation induced both cellular and exosomal miR-146a expression in BMMCs.
• Inhibition or absence of miR-146a led to enhanced cytokine production in response to IL-33.
• In vivo, IL-33 administration increased plasma exosomal miR-146a in wild-type mice, but not in mast cell-deficient mice.
• Mice reconstituted with miR-146a knockout BMMCs showed elevated IL-6 levels after IL-33 challenge.

Conclusions:

• miR-146a functions as a negative feedback regulator of IL-33-ST2 signaling.
• This regulatory pathway is primarily mediated through mast cells.
• The findings suggest miR-146a plays a critical role in controlling IL-33-driven mast cell responses relevant to allergic disease.